(EWBC) East West Bancorp - Overview
Sector: Financial ServicesIndustry: Banks - Regional | Exchange NASDAQ (USA) | Currency USD | Market Cap: 14.694m | Total Return 18.1% in 12m
Stock: Loans, Deposits, Banking, Financing, Wealth Management
Total Rating 50
Risk 62
Buy Signal 0.01
| Risk 5d forecast | |
|---|---|
| Volatility | 29.4% |
| Relative Tail Risk | -6.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.54 |
| Alpha | 1.76 |
| Character TTM | |
|---|---|
| Beta | 1.212 |
| Beta Downside | 1.698 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.77% |
| CAGR/Max DD | 0.79 |
EPS (Earnings per Share)
Revenue
Description: EWBC East West Bancorp March 04, 2026
East West Bancorp, Inc. (EWBC) is a bank holding company operating East West Bank. It provides personal and commercial banking services in the United States.
The company operates through Consumer and Business Banking, Commercial Banking, and Other segments. Its offerings include diverse deposit products like checking, savings, money market, and time deposits. Regional banks, like East West Bank, typically focus on community-based financial services and local economic development.
EWBC offers a variety of loan products, including mortgage, commercial and residential real estate, construction, and commercial business loans. The bank also provides specialized financing for business transactions between the United States and Asia, a common strategy for banks targeting specific international trade corridors. Additional services include foreign exchange, treasury management, wealth management, and risk hedging.
For more detailed financial analysis, consider exploring ValueRay.
Headlines to watch out for
- Net interest margin compression impacts profitability
- Loan growth in commercial real estate drives revenue
- Regulatory changes in banking sector increase compliance costs
- Economic slowdown reduces loan demand
- US-Asia trade relations influence international banking services
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 1.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.01 > 1.0 |
| NWC/Revenue: -43.26% < 20% (prev -1.44k%; Δ 1.40k% < -1%) |
| CFO/TA 0.02 > 3% & CFO 1.50b > Net Income 1.33b |
| Net Debt (2.52b) to EBITDA (2.03b): 1.24 < 3 |
| Current Ratio: 0.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (139.1m) vs 12m ago -0.56% < -2% |
| Gross Margin: 60.10% > 18% (prev 0.48%; Δ 5.96k% > 0.5%) |
| Asset Turnover: 5.99% > 50% (prev 5.28%; Δ 0.72% > 0%) |
| Interest Coverage Ratio: 1.01 > 6 (EBITDA TTM 2.03b / Interest Expense TTM 1.74b) |
Altman Z'' 0.44
| A: -0.03 (Total Current Assets 971.8m - Total Current Liabilities 3.00b) / Total Assets 80.43b |
| B: 0.10 (Retained Earnings 8.30b / Total Assets 80.43b) |
| C: 0.02 (EBIT TTM 1.76b / Avg Total Assets 78.21b) |
| D: 0.11 (Book Value of Equity 7.96b / Total Liabilities 71.54b) |
| Altman-Z'' Score: 0.44 = B |
Beneish M
| DSRI: none (Receivables 315.7m/none, Revenue 4.69b/4.01b) |
| GMI: 0.80 (GM 60.10% / 47.90%) |
| AQI: 1.06 (AQ_t 0.99 / AQ_t-1 0.93) |
| SGI: 1.17 (Revenue 4.69b / 4.01b) |
| TATA: -0.00 (NI 1.33b - CFO 1.50b) / TA 80.43b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of EWBC shares?
As of March 27, 2026, the stock is trading at USD 106.13 with a total of 840,301 shares traded.
Over the past week, the price has changed by +0.67%, over one month by -8.90%, over three months by -7.87% and over the past year by +18.08%.
Over the past week, the price has changed by +0.67%, over one month by -8.90%, over three months by -7.87% and over the past year by +18.08%.
Is EWBC a buy, sell or hold?
East West Bancorp has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy EWBC.
- StrongBuy: 5
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EWBC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 132.1 | 24.4% |
| Analysts Target Price | 132.1 | 24.4% |
EWBC Fundamental Data Overview March 27, 2026
P/E Trailing = 11.1103
P/E Forward = 14.9031
P/S = 5.4481
P/B = 1.6011
P/EG = 5.5751
Revenue TTM = 4.69b USD
EBIT TTM = 1.76b USD
EBITDA TTM = 2.03b USD
Long Term Debt = 3.04b USD (from longTermDebt, last quarter)
Short Term Debt = 3.00b USD (from shortTermDebt, last quarter)
Debt = 3.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.52b USD (from netDebt column, last quarter)
Enterprise Value = 17.21b USD (14.69b + Debt 3.17b - CCE 656.1m)
Interest Coverage Ratio = 1.01 (Ebit TTM 1.76b / Interest Expense TTM 1.74b)
EV/FCF = 11.46x (Enterprise Value 17.21b / FCF TTM 1.50b)
FCF Yield = 8.72% (FCF TTM 1.50b / Enterprise Value 17.21b)
FCF Margin = 32.03% (FCF TTM 1.50b / Revenue TTM 4.69b)
Net Margin = 28.27% (Net Income TTM 1.33b / Revenue TTM 4.69b)
Gross Margin = 60.10% ((Revenue TTM 4.69b - Cost of Revenue TTM 1.87b) / Revenue TTM)
Gross Margin QoQ = 64.63% (prev 61.10%)
Tobins Q-Ratio = 0.21 (Enterprise Value 17.21b / Total Assets 80.43b)
Interest Expense / Debt = 13.08% (Interest Expense 415.0m / Debt 3.17b)
Taxrate = 23.70% (110.7m / 466.9m)
NOPAT = 1.34b (EBIT 1.76b * (1 - 23.70%))
Current Ratio = 0.32 (Total Current Assets 971.8m / Total Current Liabilities 3.00b)
Debt / Equity = 0.36 (Debt 3.17b / totalStockholderEquity, last quarter 8.90b)
Debt / EBITDA = 1.24 (Net Debt 2.52b / EBITDA 2.03b)
Debt / FCF = 1.68 (Net Debt 2.52b / FCF TTM 1.50b)
Total Stockholder Equity = 8.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.69% (Net Income 1.33b / Total Assets 80.43b)
RoE = 15.77% (Net Income TTM 1.33b / Total Stockholder Equity 8.40b)
RoCE = 15.35% (EBIT 1.76b / Capital Employed (Equity 8.40b + L.T.Debt 3.04b))
RoIC = 11.46% (NOPAT 1.34b / Invested Capital 11.69b)
WACC = 10.20% (E(14.69b)/V(17.87b) * Re(10.25%) + D(3.17b)/V(17.87b) * Rd(13.08%) * (1-Tc(0.24)))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.82%
[DCF] Terminal Value 70.29% ; FCFF base≈1.47b ; Y1≈1.43b ; Y5≈1.43b
[DCF] Fair Price = 112.2 (EV 17.95b - Net Debt 2.52b = Equity 15.44b / Shares 137.6m; r=10.20% [WACC]; 5y FCF grow -3.75% → 3.0% )
EPS Correlation: 62.36 | EPS CAGR: 11.77% | SUE: 0.24 | # QB: 0
Revenue Correlation: 75.12 | Revenue CAGR: 25.07% | SUE: 3.92 | # QB: 4
EPS next Quarter (2026-06-30): EPS=2.53 | Chg7d=-0.001 | Chg30d=+0.001 | Revisions Net=+4 | Analysts=15
EPS current Year (2026-12-31): EPS=10.26 | Chg7d=-0.003 | Chg30d=+0.003 | Revisions Net=+8 | Growth EPS=+8.1% | Growth Revenue=+5.9%
EPS next Year (2027-12-31): EPS=10.96 | Chg7d=-0.003 | Chg30d=+0.003 | Revisions Net=+1 | Growth EPS=+6.8% | Growth Revenue=+6.6%
[Analyst] Revisions Ratio: +0.33 (8 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.2% (Discount Rate 10.2% - Earnings Yield 9.0%)
[Growth] Growth Spread = +7.9% (Analyst 9.2% - Implied 1.2%)
P/E Forward = 14.9031
P/S = 5.4481
P/B = 1.6011
P/EG = 5.5751
Revenue TTM = 4.69b USD
EBIT TTM = 1.76b USD
EBITDA TTM = 2.03b USD
Long Term Debt = 3.04b USD (from longTermDebt, last quarter)
Short Term Debt = 3.00b USD (from shortTermDebt, last quarter)
Debt = 3.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.52b USD (from netDebt column, last quarter)
Enterprise Value = 17.21b USD (14.69b + Debt 3.17b - CCE 656.1m)
Interest Coverage Ratio = 1.01 (Ebit TTM 1.76b / Interest Expense TTM 1.74b)
EV/FCF = 11.46x (Enterprise Value 17.21b / FCF TTM 1.50b)
FCF Yield = 8.72% (FCF TTM 1.50b / Enterprise Value 17.21b)
FCF Margin = 32.03% (FCF TTM 1.50b / Revenue TTM 4.69b)
Net Margin = 28.27% (Net Income TTM 1.33b / Revenue TTM 4.69b)
Gross Margin = 60.10% ((Revenue TTM 4.69b - Cost of Revenue TTM 1.87b) / Revenue TTM)
Gross Margin QoQ = 64.63% (prev 61.10%)
Tobins Q-Ratio = 0.21 (Enterprise Value 17.21b / Total Assets 80.43b)
Interest Expense / Debt = 13.08% (Interest Expense 415.0m / Debt 3.17b)
Taxrate = 23.70% (110.7m / 466.9m)
NOPAT = 1.34b (EBIT 1.76b * (1 - 23.70%))
Current Ratio = 0.32 (Total Current Assets 971.8m / Total Current Liabilities 3.00b)
Debt / Equity = 0.36 (Debt 3.17b / totalStockholderEquity, last quarter 8.90b)
Debt / EBITDA = 1.24 (Net Debt 2.52b / EBITDA 2.03b)
Debt / FCF = 1.68 (Net Debt 2.52b / FCF TTM 1.50b)
Total Stockholder Equity = 8.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.69% (Net Income 1.33b / Total Assets 80.43b)
RoE = 15.77% (Net Income TTM 1.33b / Total Stockholder Equity 8.40b)
RoCE = 15.35% (EBIT 1.76b / Capital Employed (Equity 8.40b + L.T.Debt 3.04b))
RoIC = 11.46% (NOPAT 1.34b / Invested Capital 11.69b)
WACC = 10.20% (E(14.69b)/V(17.87b) * Re(10.25%) + D(3.17b)/V(17.87b) * Rd(13.08%) * (1-Tc(0.24)))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.82%
[DCF] Terminal Value 70.29% ; FCFF base≈1.47b ; Y1≈1.43b ; Y5≈1.43b
[DCF] Fair Price = 112.2 (EV 17.95b - Net Debt 2.52b = Equity 15.44b / Shares 137.6m; r=10.20% [WACC]; 5y FCF grow -3.75% → 3.0% )
EPS Correlation: 62.36 | EPS CAGR: 11.77% | SUE: 0.24 | # QB: 0
Revenue Correlation: 75.12 | Revenue CAGR: 25.07% | SUE: 3.92 | # QB: 4
EPS next Quarter (2026-06-30): EPS=2.53 | Chg7d=-0.001 | Chg30d=+0.001 | Revisions Net=+4 | Analysts=15
EPS current Year (2026-12-31): EPS=10.26 | Chg7d=-0.003 | Chg30d=+0.003 | Revisions Net=+8 | Growth EPS=+8.1% | Growth Revenue=+5.9%
EPS next Year (2027-12-31): EPS=10.96 | Chg7d=-0.003 | Chg30d=+0.003 | Revisions Net=+1 | Growth EPS=+6.8% | Growth Revenue=+6.6%
[Analyst] Revisions Ratio: +0.33 (8 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.2% (Discount Rate 10.2% - Earnings Yield 9.0%)
[Growth] Growth Spread = +7.9% (Analyst 9.2% - Implied 1.2%)